News and Events

ArtVentive at GEST 2019

Visit us at GEST 2019, Booth # 111 ArtVentive Medical will participate in the 13th Annual GEST Meeting to be held from May 9 -12, In the Sheraton New York Times Square Hotel, New York City, NY.  ArtVentive will feature an exhibit booth, hands on product demonstration...

ArtVentive at SIR-2019

Visit us at SIR-2019, Booth # 705 ArtVentive Medical will participate in the Annual Scientific Meeting of the US Society of Interventional Radiology (SIR-2019). The meeting will be held on March 24-27 in Austin, TX.  ArtVentive will feature an exhibit booth, hands on...

Extended CE Mark certification for the EOS Plug

ArtVentive obtained the CE Mark extension for its flagship product: EOS vascular Plug. The extension of the European Certificate is enabling ArtVentive commercial activities in EU for the next 5 years.   The ArtVentive Endoluminal Occlusion System, EOS Plug is...

News Release: Corporate Update – APRIL 2017

We started commercial sales activity of the ArtVentive EOS™ in April 2016. From the very beginning, ArtVentive adopted a focused approach to the sales process, development and continuous growth. In the European markets, we market and sell our products through industry distributors. In the U.S, we market directly to selected University Hospitals and private clinics constantly expanding of customer base. We have targeted sales and marketing efforts to interventional radiologists and vascular surgeons with experience using similar catheter-based procedures, such as angioplasty and stenting. Peer-to-peer education is also a key element of our sales strategy.

Our progress to date has been significant where we have achieved 400 – 500% sales growth per quarter. Management is very confident in the sales development and our company’s expansion based on natural organic growth.